Sertaconazole

Brand names: Ertaczo · Active ingredient: Sertaconazole Nitrate

In short: ERTACZO ®cream, 2%, is indicated for the topical treatment of interdigital tinea pedis in immunocompetent adult and pediatric patients 12 years of age and older caused by Trichophyton rubrum, Trichophyton mentagrophytes,and Epidermophyton floccosum.

Forms & strengthsCream, 2%. Each gram of ERTACZO cream, 2%, contains 17.5 mg of sertaconazole (as sertaconazole nitrate, 20 mg) in a white cream base.
LabelCoral Way Pharma, LLC
Label updatedApr 09, 2026

What is Sertaconazole used for?

ERTACZO

®cream, 2%, is indicated for the topical treatment of interdigital tinea pedis in immunocompetent adult and pediatric patients 12 years of age and older caused by

Trichophyton rubrum,

Trichophyton mentagrophytes,and

Epidermophyton floccosum.

Sertaconazole dosage

Apply ERTACZO cream, 2% twice daily for 4 weeks. Apply a sufficient amount of ERTACZO cream, 2% to cover both the affected areas between the toes and the immediately surrounding healthy skin.

Use ERTACZO cream, 2% for the full treatment time recommended by the physician, even though symptoms may have improved.

Dry the affected area(s) thoroughly before application, if using ERTACZO cream, 2% after bathing.

Wash hands after use.

Avoid the use of occlusive dressings or wrappings.

For topical use.

Not for ophthalmic, oral, or intravaginal use.

How to take Sertaconazole — instructions & advice from the label

Advise the patient to read the FDA-approved patient labeling (Patient Information).

Instruct the patient of the following:

Administration Instructions

ERTACZO cream, 2% is for topical use only.

Avoid contact with the eyes, mouth, vagina, and other mucous membranes.

Dry the affected area(s) thoroughly before application, if using ERTACZO cream, 2% after bathing.

Wash hands after use.

Use the medication for the full treatment time recommended by the physician, even though symptoms may have improved.

Avoid the use of occlusive dressings unless otherwise directed by the physician

.

Local Adverse Reactions

Inform the physician if the area of application shows signs of increased irritation, redness, itching, burning, blistering, swelling, or oozing

.

Distributed by:

Coral Way Pharma, LLC

San Antonio, TX 78213 USA

Manufactured by:

DPT Laboratories, Ltd.

San Antonio, TX 78215

ERTACZO is a trademark of Lacer Pharma, LLC

141379

Warnings & precautions

Do not take this medicine if: None.

If irritation develops, discontinue treatment and institute appropriate therapy.

Physicians should exercise caution when prescribing ERTACZO cream, 2%, to patients known to be sensitive to azole antifungals since cross-reactivity may occur.

Sertaconazole side effects

-

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

In clinical trials, cutaneous adverse events occurred in 7 of 297 (2%) subjects (2 of them severe) receiving ERTACZO cream, 2%, and in 7 of 291 (2%) subjects (2 of them severe) receiving vehicle. These reported cutaneous adverse events included contact dermatitis, dry skin, burning skin, and application site skin tenderness.

In a dermal sensitization trial, 8 of 202 evaluable subjects tested with ERTACZO cream, 2%, and 4 of 202 evaluable subjects tested with vehicle exhibited a erythematous reaction in the challenge phase. There was no evidence of cumulative irritation or contact sensitization in a repeated insult patch test involving 202 healthy volunteers.

The following adverse reactions have been identified during post-approval use of ERTACZO cream, 2%. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Cutaneous adverse events:erythema, pruritus, vesiculation, desquamation, and hyperpigmentation.

About this medicine

ERTACZO (sertaconazole nitrate) cream, 2%, is for topical application. It contains the azole antifungal, sertaconazole nitrate. Sertaconazole nitrate contains one asymmetric carbon atom and exists as a racemic mixture of equal amounts of R and S enantiomers.

Sertaconazole nitrate is designated chemically as (±)-1-[2,4-dichloro-β-[(7-chlorobenzo-[

b]thien-3-yl)methoxy]phenethyl]imidazole nitrate. It has a molecular weight of 500.8. The molecular formula is C

20H

15Cl

3N

2OS ● HNO

3, and the structural formula is as follows:

Sertaconazole nitrate is a white or almost white powder. It is practically insoluble in water, soluble in methanol, and sparingly soluble in alcohol and in methylene chloride. Each gram of ERTACZO cream, 2%, contains 17.5 mg of sertaconazole (as sertaconazole nitrate, 20 mg) in a white cream base of ethylene glycol, glyceryl isostearate, glycolized saturated glycerides, light mineral oil, methylparaben, polyethylene glycol palmitostearate, polyoxyethylened saturated glycerides, purified water, and sorbic acid. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID c6fa8dc4-2620-474e-a9b4-6657d9cbfa96. Read the full official label on DailyMed.